Read + Share
Gemelli M. "Brief Report: Canadian Cancer Trials Group IND.227": Unpacking the Clinical
Potential of Single-Agent Pembrolizumab in Advanced Malignant Pleural
Mesothelioma. J Thorac Oncol 2023;18:e67-e68.
PMID: 37210188
|
 |
|
Gemelli M. "Brief Report: Canadian Cancer Trials Group IND.227": Unpacking the Clinical
Potential of Single-Agent Pembrolizumab in Advanced Malignant Pleural
Mesothelioma. J Thorac Oncol 2023;18:e67-e68.
PMID: 37210188
|
|
|
|